The Transcriptomic Imperative

The Journal of Medical Primatology has long served as the primary steward for the “gold standard” in biomedical modeling [1]. However, to maintain this leadership, we must bridge the persistent translational gap by shifting our focus from phylogenetic proximity to molecular precision. While non-human primates (NHPs) remain our most sophisticated proxies, high-resolution comparative transcriptomics reveal that physiological similarity does not always equate to functional parity. Recent benchmarks in single-cell RNA sequencing have identified significant “molecular drift” in cellular subpopulations across the primate lineage [2]. Even when gross neuroanatomy is conserved, the specific gene expression patterns governing neuroinflammation and synaptic plasticity—the very targets of our most ambitious therapies—exhibit critical species-specific divergences [3]. I propose that the future of translational primatology requires the adoption of Transcriptomic-Informed Selection (TIS). We must move beyond treating NHPs as “anatomical surrogates” and begin utilizing them as precision instruments. By implementing “Fidelity Scores” that quantify the single-cell alignment between NHP models and human pathological states, we can systematically mitigate the risk of Phase III clinical failures. The prestige of this journal's contributions depends on evolving the definition of a “valid model.” The next frontier of the “gold standard” will not be defined by how much a model looks like us, but by how precisely its cellular machinery mirrors human biological intent at the transcriptomic level. The author declares no conflicts of interest. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.